La eficacia de metformina y exenatida en pacientes con síndrome de ovario poliquístico (SOP)

Autor: Sanggeeta Kesavan, Gul-e-Saba Chaudhry, Abdah Md Akim, Yazan K Ranneh

Publikováno v: Ars Pharmaceutica (Internet). 64:100-122

Introduction: Polycystic Ovary Syndrome (PCOS) is a hormonal disorder that affects 5-10% of women who are their reproductive age. This meta-analysis aims to evaluate the efficacy of metformin and exenatide, respectively, and to compare the efficacy o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa769589791ee817466b53719e125407
https://doi.org/10.30827/ars.v64i2.27302

Medicamentos con efecto incretina uso intrahospitalario

Autor: Acosta Ospina, María Fernanda, Hurtado Amézquita, Yesid Camilo

Publikováno v: Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario

Introducción: La diabetes mellitus tipo 2 es una enfermedad con alta prevalencia a nivel mundial y su incidencia aumenta a medida que pasan los años, por lo que es frecuente que los pacientes que se encuentran hospitalizados por diversas causas ten

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1ab766cc54a1698882654d8d4231e68

Short-term protocols to obtain insulin-producing cells from rat adipose tissue : signaling pathways and in vivo effect

Autor: Carlos Alberto Gonçalves, Nicholas Guerini Selistre, Letícia Rodrigues, Lucas Zingano Suardi, Bárbara Carolina Federhen, Patrícia Sesterheim, Krista Minéia Wartchow

Publikováno v: Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
International Journal of Molecular Sciences, Vol 20, Iss 10, p 2458 (2019)
International Journal of Molecular Sciences
Volume 20
Issue 10

Studies using mesenchymal stromal cells (MSCs) as a source of insulin-secreting cells (IPCs) are a promising path in the pursuit for diabetes therapy. Here, we investigate three short-term differentiation protocols in order to generate IPCs from auto

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c044b03ebd452571aee5138b758c2b4d

Estudio de los mecanismos implicados en la actividad anti-inflamatoria a nivel arterial del exenatida

Autor: Martínez de Marañón Peris, Aranzazu

Publikováno v: RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
instname

[EN] Introduction and Objectives: Exenatida is a glucagon-like peptide 1 (GLP-1) analog that is used in the treatment of type 2 diabetes (T2D). However, recent observations suggest that in addition to its antidiabetic action it can exert pleiotropic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b28130553f2b784db63c123d8b4c9337
https://hdl.handle.net/10251/66817

Incretinomiméticos e inibidores da dipeptidil peptidase-4: terapias inovadoras para o tratamento do diabetes tipo 2

Autor: Jaime A. Davidson, Jorge Luiz Gross, Erika B. Parente

Publikováno v: Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Arquivos Brasileiros de Endocrinologia & Metabologia v.52 n.6 2008
Arquivos Brasileiros de Endocrinologia & Metabologia
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
Arquivos Brasileiros de Endocrinologia & Metabologia, Volume: 52, Issue: 6, Pages: 1039-1049, Published: AUG 2008

The prevalence of diabetes and impaired glucose tolerance is predicted to dramatically increase over the next two decades. Clinical therapies for type 2 diabetes mellitus (T2DM) have traditionally included lifestyle modification, oral anti-diabetic a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a0eeab3843f7cc604e1db9a2e6ced44
https://doi.org/10.1590/s0004-27302008000600016